0001618835-23-000007.txt : 20230203
0001618835-23-000007.hdr.sgml : 20230203
20230203170218
ACCESSION NUMBER: 0001618835-23-000007
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230203
DATE AS OF CHANGE: 20230203
EFFECTIVENESS DATE: 20230203
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evofem Biosciences, Inc.
CENTRAL INDEX KEY: 0001618835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208527075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-472618
FILM NUMBER: 23587018
BUSINESS ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 600
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 550-1900
MAIL ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 600
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Neothetics, Inc.
DATE OF NAME CHANGE: 20140905
D
1
primary_doc.xml
X0708
D
LIVE
0001618835
Evofem Biosciences, Inc.
12400 HIGH BLUFF DRIVE, SUITE 600
SAN DIEGO
CA
CALIFORNIA
92130
(858) 550-1900
DELAWARE
Neothetics, Inc.
Corporation
true
Saundra
Pelletier
12400 High Bluff Drive, Suite 600
San Diego
CA
CALIFORNIA
92130
Executive Officer
Director
Justin
File
12400 High Bluff Drive, Suite 600
San Diego
CA
CALIFORNIA
92130
Executive Officer
Gillian
Greer
12400 High Bluff Drive, Suite 600
San Diego
CA
CALIFORNIA
92130
Director
Kim
Kamdar
12400 High Bluff Drive, Suite 600
San Diego
CA
CALIFORNIA
92130
Director
Tony
O'Brian
12400 High Bluff Drive, Suite 600
San Diego
CA
CALIFORNIA
92130
Director
Colin
Rutherford
12400 High Bluff Drive, Suite 600
San Diego
CA
CALIFORNIA
92130
Director
Lisa
Rarick
12400 High Bluff Drive, Suite 600
San Diego
CA
CALIFORNIA
92130
Director
Jenny
Yip
12400 High Bluff Drive, Suite 600
San Diego
CA
CALIFORNIA
92130
Director
Biotechnology
Decline to Disclose
- 06b
false
2022-12-20
false
true
true
true
false
0
2307693
2307693
0
false
8
0
0
0
false
Evofem Biosciences, Inc.
/s/ Justin J. File
Justin J. File
Chief Financial Officer
2023-02-01